<div id="readability-page-1"><div><p>As the pan-European STOXX Europe 600 Index experiences a positive uptick amid easing geopolitical tensions and corporate earnings reports, attention is turning towards small-cap stocks that may present unique opportunities in this dynamic environment. In the context of these market conditions, investors often look for companies with strong fundamentals and potential for growth, particularly when there is notable insider activity suggesting confidence from those within the company.</p><h3>Top 10 Undervalued Small Caps With Insider Buying In Europe</h3><p> Click here to see the full list of 78 stocks from our Undervalued European Small Caps With Insider Buying screener.     </p><p>Let's explore several standout options from the results in the screener.</p><h2>Garofalo Health Care (BIT:GHC)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Garofalo Health Care operates a network of healthcare facilities providing a range of medical services across Italy, with a market capitalization of approximately €0.67 billion.</p><p><strong>Operations:</strong> Garofalo Health Care generates revenue primarily through its core operations, with a recent reported revenue of €485.12 million as of December 31, 2025. The company's cost of goods sold (COGS) was €381.23 million for the same period, impacting its gross profit margin which stood at 21.42%. Operating expenses and non-operating expenses contribute to the overall financial structure, influencing net income outcomes over time.</p><p><strong>PE:</strong> 18.1x</p><p>Garofalo Health Care, a small cap in Europe, has caught attention with its recent financial moves. Despite high external debt reliance, their revenue grew to €487 million for 2025, up from €471 million the previous year. Net income also increased to €23 million. Insider confidence is evident with share purchases by executives between October and December 2025. A dividend increase to €0.093 per share reflects potential growth prospects amidst cautious financial structuring and strategic presentations at industry conferences in March 2026.</p><ul><li>Get an in-depth perspective on Garofalo Health Care's performance by reading our valuation report here.</li><li>Gain insights into Garofalo Health Care's past trends and performance with our Past report.</li></ul><h2>Secure Trust Bank (LSE:STB)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Secure Trust Bank is a UK-based retail and commercial bank that provides a range of banking services, including personal savings, mortgages, and business finance solutions, with a market cap of approximately £0.15 billion.</p><p><strong>Operations:</strong> Secure Trust Bank generates revenue primarily through its financial services, with recent figures showing £149.61 million in revenue as of June 2025. The company's operating expenses have been a significant factor, reaching £103.91 million in the same period. Notably, the net income margin has shown variability over time, peaking at 33.33% by December 2025 after periods of lower margins such as 14.84% in March 2025.</p><p><strong>PE:</strong> 6.0x</p><p>Secure Trust Bank, a smaller European financial player, has caught attention due to its potential value. Despite a slight dip in net income to £17.6 million for 2025, insider confidence is evident with James Raymond Brown's purchase of 25,000 shares worth approximately £229K in recent months. The bank's high bad loan ratio of 3.6% contrasts with low allowances at 36%, yet growth prospects are promising with earnings projected to rise annually by over 17%.</p><ul><li>Delve into the full analysis valuation report here for a deeper understanding of Secure Trust Bank.</li><li>Gain insights into Secure Trust Bank's historical performance by reviewing our past performance report.</li></ul><h2>Vistry Group (LSE:VTY)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Vistry Group is a UK-based company primarily engaged in residential and commercial home building, with a market capitalization of approximately £1.96 billion.</p><p><strong>Operations:</strong> Vistry Group's revenue primarily stems from its Home Builders segment, generating £3.61 billion. The company's cost of goods sold (COGS) accounts for a significant portion of expenses, with a gross profit margin of 10.78% as of the latest period. Operating expenses and non-operating expenses further impact financial outcomes, contributing to a net income margin of 3.82%.</p><p><strong>PE:</strong> 8.5x</p><p>Vistry Group, a notable player in the UK housebuilding sector, has seen significant insider confidence with Gregory Fitzgerald purchasing 219,377 shares worth £893,303 between March and April 2026. Despite a volatile share price recently, the company projects a promising earnings growth of 14.12% annually. Recent leadership changes include Adam Daniels stepping in as CEO on April 13, 2026. Vistry's full-year net income rose to £138 million from £74.5 million previously, indicating potential for continued growth amidst strategic transitions and partnerships-led expansion efforts.</p><ul><li>Click to explore a detailed breakdown of our findings in Vistry Group's valuation report.</li><li>Explore historical data to track Vistry Group's performance over time in our Past section.</li></ul><h2>Turning Ideas Into Actions</h2><ul><li>Click this link to deep-dive into the 78 companies within our Undervalued European Small Caps With Insider Buying screener.</li><li>Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.</li><li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li></ul><h2>Ready For A Different Approach?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p></div></div>

<p>As the STOXX Europe 600 Index rises, investors are focusing on undervalued small-cap stocks with insider buying activity. Notable companies include Garofalo Health Care, which reported €487 million in revenue for 2025 and a net income of €23 million, and Secure Trust Bank, with a revenue of £149.61 million and a projected earnings growth of over 17%. Vistry Group, a UK home builder, has seen significant insider purchases and a rise in net income to £138 million. These companies present potential investment opportunities in the current market environment.</p>

European Undervalued Small Caps With Insider Action To Consider